True Wealth Design’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$206 Sell
16
-338
-95% -$2.75K ﹤0.01% 2344
2026
Q2
$3.51K Buy
354
+327
+1,211% +$2.73K ﹤0.01% 1472
2026
Q1
$166 Sell
27
-17
-39% -$141 ﹤0.01% 2366
2025
Q4
$366 Hold
44
– – ﹤0.01% 2057
2025
Q3
$642 Hold
44
– – ﹤0.01% 1925
2025
Q2
$495 Sell
44
-4
-8% -$31 ﹤0.01% 1749
2025
Q1
$274 Buy
+48
New +$489 ﹤0.01% 1817

Other funds holding DNA

True Wealth Design's DNA Position: Q3 2026 in Review

True Wealth Design reduced its Ginkgo Bioworks (DNA) stake by 95% in Q3 2026, selling an estimated $2.75K and leaving 16 shares worth $206. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

True Wealth Design first reported a position in DNA in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.51K in Q2 2026. 9 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • True Wealth Design held 16 shares of Ginkgo Bioworks worth $206 as of Q3 2026.
  • True Wealth Design sold 338 Ginkgo Bioworks shares in Q3 2026, an estimated $2.75K.
  • Ginkgo Bioworks made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2344 holding.
  • True Wealth Design first reported a position in Ginkgo Bioworks in Q1 2025 and has held it in 7 quarters since.
  • True Wealth Design's Ginkgo Bioworks position peaked at $3.51K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.